A team built to translate science into therapeutic impact

Serendo Therapeutics brings together expertise across immunology, translational medicine, drug discovery, partnering, and biotech company building. Our leadership team and advisors share a common ambition: to advance a differentiated therapeutic approach in autoimmune disease.

Leadership

Ulrika Norin

Founder & Chief Executive Officer

Ulrika Norin is the Founder and CEO of Serendo Therapeutics. Trained as an immunologist, she brings experience spanning autoimmune disease biology, translational drug discovery, and biotech company building. She leads Serendo’s scientific and strategic development with a focus on advancing precision therapies in autoimmune disease.

Lars S Andersen

Head of Strategy & Partnering

Lars Smedegaard Andersen leads strategy and partnering at Serendo Therapeutics. He brings broad pharmaceutical and biotech experience across drug development, licensing, commercialization, and strategic leadership, helping connect scientific innovation with partnership strategy and long-term value creation.

Petteri Heljo

Head of Discovery

Petteri Heljo leads discovery at Serendo Therapeutics. He brings extensive experience in pharmaceutical R&D, discovery, and preclinical development, and supports Serendo’s efforts to translate differentiated biology into therapeutically relevant candidates for autoimmune disease.

Scientific and Strategic Advisors

Serendo Therapeutics is supported by a distinguished group of advisors with deep expertise across drug discovery, autoimmune disease biology, regulatory strategy, clinical development, intellectual property, finance, and company building.

  • Konrad Koehler, PhD
    Medicinal chemist with 30+ years of experience in small-molecule drug development.
  • Rikard Holmdahl, MD, PhD
    Senior professor in experimental rheumatology with deep expertise in autoimmune disease biology.
  • Margareth Jorvid, PhD
    Regulatory expert with 30+ years of experience advancing clinical development programs.
  • Marie Mannerlöf, PhD
    IP strategist with 30+ years of experience in patent portfolio management.
  • Anders Hansen
    Clinical development expert with 20+ years of experience in global pharmaceutical companies.
  • Jesper Kihl
    Life science executive with 30+ years of experience in global pharmaceutical companies.